Sernova (TSE:SVA) Shares Down 4.3% – Here’s What Happened

Sernova Corp. (TSE:SVA)’s stock price dropped 4.3% on Monday . The stock traded as low as C$0.22 and last traded at C$0.22. Approximately 99,485 shares traded hands during trading, a decline of 38% from the average daily volume of 160,012 shares. The stock had previously closed at C$0.23.

Analyst Ratings Changes

SVA has been the subject of a number of analyst reports. Ventum Cap Mkts raised Sernova to a “strong-buy” rating in a report on Thursday, September 12th. Leede Financial lowered their price target on Sernova from C$3.00 to C$1.50 and set a “speculative buy” rating on the stock in a report on Friday, September 13th. Finally, Ventum Financial lowered their target price on Sernova from C$3.00 to C$2.50 and set a “buy” rating on the stock in a report on Friday, September 13th.

Sernova Price Performance

The stock has a fifty day simple moving average of C$0.24 and a 200-day simple moving average of C$0.27. The stock has a market cap of C$71.57 million, a price-to-earnings ratio of -1.69 and a beta of 1.35. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of 16.55.

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.